Varki N - Search Results

1

Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1.

Bissonnette M, Khare S, von Lintig FC, Wali RK, Nguyen L, Zhang Y, Hart J, Skarosi S, Varki N, Boss GR, Brasitus TA. Bissonnette M, et al. Among authors: varki n. Cancer Res. 2000 Aug 15;60(16):4602-9. Cancer Res. 2000. PMID: 10969813

2

Immunohistochemical identification of tissue factor in solid tumors.

Callander NS, Varki N, Rao LV. Callander NS, et al. Among authors: varki n. Cancer. 1992 Sep 1;70(5):1194-201. doi: 10.1002/1097-0142(19920901)70:5<1194::aid-cncr2820700528>3.0.co;2-e. Cancer. 1992. PMID: 1381270

3

De-N-acetyl-gangliosides in humans: unusual subcellular distribution of a novel tumor antigen.

Chammas R, Sonnenburg JL, Watson NE, Tai T, Farquhar MG, Varki NM, Varki A. Chammas R, et al. Among authors: varki a, varki nm. Cancer Res. 1999 Mar 15;59(6):1337-46. Cancer Res. 1999. PMID: 10096568

4

Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy.

Samimi G, Fink D, Varki NM, Husain A, Hoskins WJ, Alberts DS, Howell SB. Samimi G, et al. Among authors: varki nm. Clin Cancer Res. 2000 Apr;6(4):1415-21. Clin Cancer Res. 2000. PMID: 10778972

5

Ras activation in human breast cancer.

von Lintig FC, Dreilinger AD, Varki NM, Wallace AM, Casteel DE, Boss GR. von Lintig FC, et al. Among authors: varki nm. Breast Cancer Res Treat. 2000 Jul;62(1):51-62. doi: 10.1023/a:1006491619920. Breast Cancer Res Treat. 2000. PMID: 10989985

6

alpha 2-6-Linked sialic acids on N-glycans modulate carcinoma differentiation in vivo.

Hedlund M, Ng E, Varki A, Varki NM. Hedlund M, et al. Cancer Res. 2008 Jan 15;68(2):388-94. doi: 10.1158/0008-5472.CAN-07-1340. Cancer Res. 2008. PMID: 18199532

7

Two human tumors with high basement-membrane-producing potential.

Barsky SH, Layfield L, Varki N, Bhuta S. Barsky SH, et al. Among authors: varki n. Cancer. 1988 May 1;61(9):1798-806. doi: 10.1002/1097-0142(19880501)61:9<1798::aid-cncr2820610913>3.0.co;2-g. Cancer. 1988. PMID: 2833339

8

Elimination of established murine colon carcinoma metastases by antibody-interleukin 2 fusion protein therapy.

Xiang R, Lode HN, Dolman CS, Dreier T, Varki NM, Qian X, Lo KM, Lan Y, Super M, Gillies SD, Reisfeld RA. Xiang R, et al. Among authors: varki nm. Cancer Res. 1997 Nov 1;57(21):4948-55. Cancer Res. 1997. PMID: 9354462

9

Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: single agent and combination chemotherapy studies.

Shalinsky DR, Brekken J, Zou H, Bloom LA, McDermott CD, Zook S, Varki NM, Appelt K. Shalinsky DR, et al. Among authors: varki nm. Clin Cancer Res. 1999 Jul;5(7):1905-17. Clin Cancer Res. 1999. PMID: 10430098

10

Increase in expression of the copper transporter ATP7A during platinum drug-based treatment is associated with poor survival in ovarian cancer patients.

Samimi G, Varki NM, Wilczynski S, Safaei R, Alberts DS, Howell SB. Samimi G, et al. Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5853-9. Clin Cancer Res. 2003. PMID: 14676106

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters